Groups
RESEARCH GROUPS
Contact information
Marta González Sáenz de Tejada
Marta González holds a Bachelor’s degree in Psychology (2002) and a Ph.D. in Health and Family from the University of Deusto (2010); she also completed a Master’s degree in Mental Health (2004) at the Basque Foundation for Mental Health Research (OMIE). She has worked for 17 years in health services research at the Research Unit of Basurto University Hospital. She has been employed as a research technician by the Biomedical Research Consortium Network on Epidemiology and Public Health (CIBERESP) and by the Research Network on Health Services for Chronic Diseases (REDISSEC). She currently works in the Research Group on Dissemination and Implementation Sciences in Health Services at the IIS Biocruces Bizkaia, where she performs coordination, supervision, and research support functions for the Bizkaia Group of the Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS) (RD21/0016/0003; RD24/0005/0017).
Projects
-
AMBISiON-IMPaCT: Un proyecto de enriquecimiento de la cohorte IMPACT con medidas AMBIentales y de Salud Ocular para la medicina de preciSION
Principal Investigator: Esther García García-Esquinas
Funding entity: (2026)
-
Estudio sobre el impacto de la hipertensión arterial en la mortalidad por cualquier causa y por causa cardiovascular en población general
Principal Investigator: Bilbao Gonzalez, Amaia
Funding entity: (2021 - 2023)
-
Evaluación de la efectividad y coste efectividad de una intervención en pacientes hospitalizados con desnutrición relacionada con la enfermedad
Principal Investigator: Quintana López, José María
Funding entity: (2021 - 2023)
-
Evaluación de la efectividad y coste efectividad de una intervención en pacientes hospitalizados con desnutrición relacionada con la enfermedad
Principal Investigator: Susana García Gutiérrez
Funding entity: (2023 - 2023)
-
SMART design para evaluar la efectividad de una Intervención adaptativa para reducir el consumo de Antibióticos en atención primaria: SMART-AB
Principal Investigator: Laura Gallardo Alfaro
Funding entity: (2026)
Recent publications
-
Fabelo H, Ramallo-Fariña Y, Morera J, Piñeiro JF, Lagares A, Jiménez-Roldán L, Burström G, García-Bello MA, García-Pérez L, Falero R, González M, Duque S, Rodriguez-Jimenez C, Hernández M, Delgado-Sánchez JJ, Paredes AB, Hernández G, Ponce P, León R, González-Martín JM, Rodríguez-Esparragón F, Callicó GM, Wägner AM, Clavo B, . STRATUM-OS: first step in the development and validation of the STRATUM tool based on multimodal data processing to assist surgery in patients affected by intra-axial brain tumours - observational study protocol.. BMJ Open. 2026 Feb;16:e106584. doi:10.1136/bmjopen-2025-106584. Epub 2026 Feb 17. pmc:PMC12918683. PMID:41702662.
-
Sanchez A, Pijoan JI, Sainz de Rozas R, Lekue I, San Vicente R, Quindimil JA, Rotaeche R, Etxeberria A, Mozo C, Martinez-Cengotitabengoa M, Monge M, Gómez-Ramírez C, Vivanco L, Martin V, Merino-Inda N, Llarena M, Gonzalez Saenz de Tejada M, Garcia-Alvarez A. Comparative effectiveness of non-reflective and reflective strategies to favor de-implementation of low-value prescribing for the primary prevention of cardiovascular disease in primary care: the DE-imFAR cluster randomized implementation trial.. Implement Sci Commun. 2026 May;:. doi:10.1186/s43058-026-00968-1. Epub 2026 May 22. PMID:42174713.
-
Bilbao-González A, González-Sáenz de Tejada M, Ferrer M, Ramallo-Fariña Y, Paja-Fano M, García-Forero C, Mestre D, Gorostiza-Hormaetxe I. Psychometric properties of the EQ-5D-5L in diabetes mellitus patients in Spain.. J Patient Rep Outcomes. 2025 May;9:60. doi:10.1186/s41687-025-00874-5. Epub 2025 May 29. pmc:PMC12122406. PMID:40439786.
-
Sanchez A, Pijoan JI, Sainz de Rozas R, Lekue I, San Vicente R, Quindimil JA, Rotaeche R, Etxeberria A, Mozo C, Martinez-Cengotitabengoa M, Monge M, Gómez-Ramírez C, Samper R, Ogueta Lana M, Celorrio S, Merino-Inda N, Llarena M, Gonzalez Saenz de Tejada M, García-Alvarez A, Grandes G. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease. BMJ Open. 2024 Apr; 14(4):e078692. doi:10.1136/bmjopen-2023-078692. Epub 2024 Apr 17. pmc:PMC11029292. PMID:38631840.
-
Llarena M, Rogers HL, Macia P, Pablo S, Gonzalez-Saenz de Tejada M, Montejo M, Paniagua N, Benito J, Rueda M, Santos B, Grandes G, Sanchez A. Validity and reliability of the transculturally adapted Spanish version of the Implementation Leadership Scale (ILS). Implement Sci Commun. 2023 Sep; 4(1):112. doi:10.1186/s43058-023-00495-3. Epub 2023 Sep 12. pmc:PMC10496227. PMID:37700388.
-
Gonzalez-Saenz de Tejada M, Bilbao A, Ansola L, Quirós R, García-Perez L, Navarro G, Escobar A. Responsiveness and minimal clinically important difference of the Minnesota living with heart failure questionnaire. Health Qual Life Outcomes. 2019 Feb; 17(1):36. doi:10.1186/s12955-019-1104-2. Epub 2019 Feb 14. pmc:PMC6376687. PMID:30764842.
93 482 46 94
671 511 120
info@ricapps.es
